Jacqueline O'Brien

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Escherichia Coli

African American

Ejection Fraction

Top Venues

Clinical rheumatology

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology 43 (3) (2024)
Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology 43 (3) (2024)
Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology 43 (3) (2024)
Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology 43 (3) (2024)
Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology 43 (3) (2024)
Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology 43 (3) (2024)
Jacqueline O'Brien, Sang Hee Park, Taylor Blachley, Maya Marchese, Nicole Middaugh, Keith Wittstock, Leslie R Harrold
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups. Clinical rheumatology (2024)
Yoshiya Tanaka, Kishimoto Mitsumasa, Koshiro Sonomoto, Koichi Amano, Masayoshi Harigai, Alina Onofrei, Jacqueline O'Brien, Zachary R Margolin, Christine Barr, Yasushi Mizuno, Ekta Agarwal, Naonobu Sugiyama, Hisashi Yamanaka
Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study. Rheumatology and therapy (2024)